Bausch Health Companies Statistics
Share Statistics
Bausch Health Companies has 369.55M
shares outstanding. The number of shares has increased by 0.31%
in one year.
Shares Outstanding | 369.55M |
Shares Change (YoY) | 0.31% |
Shares Change (QoQ) | 0.04% |
Owned by Institutions (%) | 68.73% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 108,859 |
FTD / Avg. Volume | 4.36% |
Short Selling Information
The latest short interest is 9.02M, so 2.45% of the outstanding
shares have been sold short.
Short Interest | 9.02M |
Short % of Shares Out | 2.45% |
Short % of Float | 2.65% |
Short Ratio (days to cover) | 2.84 |
Valuation Ratios
The PE ratio is -67.73 and the forward
PE ratio is 1.
Bausch Health Companies's PEG ratio is
0.74.
PE Ratio | -67.73 |
Forward PE | 1 |
PS Ratio | 0.31 |
Forward PS | 0.2 |
PB Ratio | -2.32 |
P/FCF Ratio | 2.35 |
PEG Ratio | 0.74 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bausch Health Companies.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.86,
with a Debt / Equity ratio of -16.9.
Current Ratio | 0.86 |
Quick Ratio | 0.62 |
Debt / Equity | -16.9 |
Debt / EBITDA | 13.98 |
Debt / FCF | 17.16 |
Interest Coverage | 1.11 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $459,806.76 |
Profits Per Employee | $-2,115.53 |
Employee Count | 20,700 |
Asset Turnover | 0.36 |
Inventory Turnover | 1.74 |
Taxes
Income Tax | 227.52M |
Effective Tax Rate | 136.24% |
Stock Price Statistics
The stock price has increased by -32.23% in the
last 52 weeks. The beta is 0.34, so Bausch Health Companies's
price volatility has been higher than the market average.
Beta | 0.34 |
52-Week Price Change | -32.23% |
50-Day Moving Average | 5.99 |
200-Day Moving Average | 7.04 |
Relative Strength Index (RSI) | 36.61 |
Average Volume (20 Days) | 2,499,244 |
Income Statement
In the last 12 months, Bausch Health Companies had revenue of 9.52B
and earned -43.79M
in profits. Earnings per share was -0.13.
Revenue | 9.52B |
Gross Profit | 6.74B |
Operating Income | 1.55B |
Net Income | -43.79M |
EBITDA | 1.55B |
EBIT | 1.55B |
Earnings Per Share (EPS) | -0.13 |
Full Income Statement Balance Sheet
The company has 1.18B in cash and 21.62B in
debt, giving a net cash position of -20.43B.
Cash & Cash Equivalents | 1.18B |
Total Debt | 21.62B |
Net Cash | -20.43B |
Retained Earnings | -9.82B |
Total Assets | 26.52B |
Working Capital | -978M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 1.6B
and capital expenditures -337M, giving a free cash flow of 1.26B.
Operating Cash Flow | 1.6B |
Capital Expenditures | -337M |
Free Cash Flow | 1.26B |
FCF Per Share | 3.42 |
Full Cash Flow Statement Margins
Gross margin is 70.77%, with operating and profit margins of 16.24% and -0.46%.
Gross Margin | 70.77% |
Operating Margin | 16.24% |
Pretax Margin | 1.75% |
Profit Margin | -0.46% |
EBITDA Margin | 16.24% |
EBIT Margin | 16.24% |
FCF Margin | 13.24% |
Dividends & Yields
BHC pays an annual dividend of $1.37,
which amounts to a dividend yield of 4.99%.
Dividend Per Share | $1.37 |
Dividend Yield | 4.99% |
Dividend Growth (YoY) | -76% |
Payout Ratio | -1141.67% |
Earnings Yield | n/a |
FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for BHC is $8,
which is 69.9% higher than the current price. The consensus rating is "Hold".
Price Target | $8 |
Price Target Difference | 69.9% |
Analyst Consensus | Hold |
Analyst Count | 5 |
Stock Forecasts Stock Splits
The last stock split was on Oct 16, 2000. It was a
forward
split with a ratio of 2:1.
Last Split Date | Oct 16, 2000 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 0.04 |
Piotroski F-Score | 4 |